103 related items for PubMed ID: 8348221
1. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Einaudi S, Lala R, Corrias A, Matarazzo P, Pagliardini S, de Sanctis C.
J Pediatr Endocrinol; 1993; 6(2):173-8. PubMed ID: 8348221
[Abstract] [Full Text] [Related]
2. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
[Abstract] [Full Text] [Related]
3. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
4. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
Rev Chil Pediatr; 1984 Mar; 55(6):374-9. PubMed ID: 6536989
[No Abstract] [Full Text] [Related]
5. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
Nordenström A, Marcus C, Axelson M, Wedell A, Ritzén EM.
J Clin Endocrinol Metab; 1999 Apr; 84(4):1210-3. PubMed ID: 10199755
[Abstract] [Full Text] [Related]
6. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
Sólyom J, Hosszu E, Gács G.
Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
[Abstract] [Full Text] [Related]
7. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y.
Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
[Abstract] [Full Text] [Related]
8. Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia.
Ilondo MM, Vanderschueren-Lodeweyckx M, Pizarro M, Vlietinck R, Malvaux P, Eggermont E, Eeckels R.
Horm Res; 1983 Aug 20; 18(4):175-85. PubMed ID: 6227545
[Abstract] [Full Text] [Related]
9. Effect of treatment on growth in congenital adrenal hyperplasia.
Ercan O, Hatemi S, Kutlu E, Turan N.
Indian J Pediatr; 2000 Nov 20; 67(11):783-9. PubMed ID: 11216375
[Abstract] [Full Text] [Related]
10. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
Golden MP, Lippe BM, Kaplan SA, Lavin N, Slavin J.
Pediatrics; 1978 Jun 20; 61(6):867-71. PubMed ID: 149950
[Abstract] [Full Text] [Related]
11. [A case of congenital adrenogenital syndrome].
Sumiya H, Kawamura K, Kataumi Z, Fuse H, Ito H, Shimazaki J.
Hinyokika Kiyo; 1985 Aug 20; 31(8):1433-9. PubMed ID: 3878668
[Abstract] [Full Text] [Related]
12. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
Pincus DR, Kelnar CJ, Wallace AM.
J Paediatr Child Health; 1993 Aug 20; 29(4):302-4. PubMed ID: 8373678
[Abstract] [Full Text] [Related]
13. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
Lippe BM, LaFranchi SH, Lavin N, Parlow A, Coyotupa J, Kaplan SA.
J Pediatr; 1974 Dec 20; 85(6):782-7. PubMed ID: 4371221
[No Abstract] [Full Text] [Related]
14. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R, Espiner EA, Abbott GD.
N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
[Abstract] [Full Text] [Related]
15. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography.
Petersen KE, Christensen T.
Acta Paediatr Scand; 1979 Mar 11; 68(2):205-11. PubMed ID: 217232
[Abstract] [Full Text] [Related]
16. Serum 17-hydroxypregnenolone and 17-hydroxypregnenolone sulfate concentrations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Shimozawa K, Saisho S, Yata J, Kambegawa A.
Endocrinol Jpn; 1988 Feb 11; 35(1):11-8. PubMed ID: 3260857
[Abstract] [Full Text] [Related]
17. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
[Abstract] [Full Text] [Related]
18. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.
Youssefnejadian E, David R.
Clin Endocrinol (Oxf); 1975 Jul 09; 4(4):451-54. PubMed ID: 168994
[Abstract] [Full Text] [Related]
19. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov 09; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
20. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Nov 09; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
